Literature DB >> 6202407

Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).

R Vriesendorp, J G Aalders, D T Sleijfer, P H Willemse, J Bouma, N H Mulder.   

Abstract

Seven patients with germ cell tumors of the ovary were treated with four cycles of cisplatin, vinblastine, and bleomycin. Six patients were without evidence of disease 17+ to 37+ months after completion of the remission-induction chemotherapy, and one patient relapsed after 9 months. Substantial toxicity of the cisplatin, vinblastine, and bleomycin regimen was noted. Despite the high response rate suggested in this small series, the optimal chemotherapeutic treatment for this disease has yet to be determined.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202407

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  3 in total

1.  Malignant mixed ovarian germ cell tumor with embryonal component.

Authors:  Natalie Catharine Moniaga; Leslie M Randall
Journal:  J Pediatr Adolesc Gynecol       Date:  2010-09-24       Impact factor: 1.814

2.  Combination chemotherapy in malignant non-seminomatous germ-cell tumors: results of a cooperative study of the German Society of Pediatric Oncology (MAKEI 83).

Authors:  U Gobel; G Calaminus; R J Häas; H Jurgens; D Niethammer; J Ritter; H J Spaar; D Harms
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 3.  Cisplatin: a review of clinical applications and renal toxicity.

Authors:  D T Sleijfer; S Meijer; N H Mulder
Journal:  Pharm Weekbl Sci       Date:  1985-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.